Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy

EuroIntervention 2018;13:1946-1949 published online January 2018. DOI: 10.4244/EIJ-D-17-00720

Christoph Jensen
Christoph J. Jensen1*, MD; Christoph K. Naber1, MD; Philip Urban2, MD; Paul J. Ong3, MD; Mariano Valdes-Chavarri4, MD; Alexandre A. Abizaid5, MD; Stuart J. Pocock6, MD; Franco Fabbiocchi7, MD; Christophe Dubois8, MD; Samuel Copt9, PhD; Hans-Peter Stoll9, MD; Marie-Claude Morice10, MD; for the LEADERS FREE Investigators
1. Contilia Heart and Vascular Centre, Elisabeth Krankenhaus Essen, Essen, Germany; 2. Hospital de la Tour, Geneva, Switzerland; 3. Tan Tock Seng Hospital, Singapore, Singapore; 4. Hospital Universitario Virgen de la Arrixaca, Murcia, Spain; 5. Instituto

In patients with acute coronary syndrome (ACS) undergoing PCI, bleeding is associated with increased mortality1. An abbreviated dual antiplatelet therapy (DAPT) is recommended after drug-eluting

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Randomised comparison of JUDkins vs. tiGEr catheter in coronary angiography via the right radial artery: the JUDGE study

Latest news